Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...
Reuters5d
Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free
Nov 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections. The results ...
New Atlas8d
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
NBC Los Angeles7d
Amgen says no concerns around weight loss drug's bone density data after stock falls
The drug is a promising potential competitor in the weight loss drug market. It is designed to be taken monthly, rather than ...
Is Viking Therapeutics a Buy on the Dip?
A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
NBC New York10d
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Apart from its pill, Viking is developing a weight loss injection and other treatments ... injectable treatments from Novo Nordisk and Eli Lilly. Patients with diabetes lost 5.8% of their ...